DEXISUN

This brand name is authorized in South Africa

Active ingredients

The drug DEXISUN contains one active pharmaceutical ingredient (API):

1 Dexmedetomidine UNII 1018WH7F9I - DEXMEDETOMIDINE HYDROCHLORIDE

Dexmedetomidine is a selective alpha-2 receptor agonist with a broad range of pharmacological properties. It has a sympatholytic effect through decrease of the release of noradrenaline in sympathetic nerve endings. The sedative effects are mediated through decreased firing of locus coeruleus, the predominant noradrenergic nucleus, situated in the brainstem. Read about Dexmedetomidine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEXISUN Concentrated solution for infusion	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CM18	Dexmedetomidine	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CM Other hypnotics and sedatives
Discover more medicines within N05CM18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 54/2.9/0218